Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

KZIA Kazia Therapeutics Ltd

0,28

-0,006 (-2,10%)

Zuletzt aktualisiert: 19:32:27

Verzögert um 15 Minuten

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Kazia Therapeutics (NASDAQ:KZIA)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Kazia Therapeutics Charts.

Kazia Therapeutics (NASDAQ:KZIA)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Kazia Therapeutics Charts.

News Kazia Therapeutics Ltd

KAZIA REPORTS SUCCESSFUL STAGE 1 COMPLETION OF THE EVT801 PHASE 1 CLINICAL TRIAL IN ADVANCED CANCER PATIENTS
Mittwoch 1 Mai 2024 (2 Wochen vor) • PR Newswire (US)

Kazia Therapeutics licenses paxalisib to Sovargen for intractable seizures in rare central nervous system diseases
Donnerstag 21 März 2024 (2 Monate vor) • PR Newswire (US)

Kazia announces presentation of new data at AACR Annual Meeting
Mittwoch 13 März 2024 (2 Monate vor) • PR Newswire (US)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Mittwoch 21 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mittwoch 21 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Kazia Therapeutics Reports Early Conclusion of Clinical Trial After Reaching Primary Endpoint
Mittwoch 21 Februar 2024 (3 Monate vor) • PR Newswire (US)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dienstag 13 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Dienstag 6 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Montag 5 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Donnerstag 18 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

KAZIA CONTINUES BOARD RENEWAL WITH TWO NEW APPOINTMENTS
Donnerstag 18 Januar 2024 (4 Monate vor) • PR Newswire (US)

Weitere Kazia Therapeutics Ltd News-Artikel

Elanor Investors

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen